4.7 Article

Novel oral edaravone attenuates diastolic dysfunction of diabetic cardiomyopathy by activating the Nrf2 signaling pathway

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Cardiac & Cardiovascular Systems

NRF2 in Cardiovascular Diseases: a Ray of Hope!

Ruju Vashi et al.

Summary: Heart failure is a global pandemic affecting millions worldwide. Imbalanced redox homeostasis in cardiac cells leads to various cardiovascular diseases, with NRF2 potentially serving as a target for treatment. NRF2 activators may attenuate hemodynamic stress and have therapeutic effects in cardiovascular diseases.

JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2021)

Article Cell Biology

Inactivation of TOPK Caused by Hyperglycemia Blocks Diabetic Heart Sensitivity to Sevoflurane Postconditioning by Impairing the PTEN/PI3K/Akt Signaling

Sumin Gao et al.

Summary: The cardioprotective effect of sevoflurane postconditioning (SPostC) is mediated by TOPK-induced activation of PTEN/PI3K/Akt signaling pathway in nondiabetic conditions, while its impairment in diabetic conditions leads to loss of cardioprotection by SPostC.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)

Article Cardiac & Cardiovascular Systems

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Theresa A. McDonagh et al.

EUROPEAN HEART JOURNAL (2021)

Article Cell Biology

Mitoquinone Protects Podocytes from Angiotensin II-Induced Mitochondrial Dysfunction and Injury via the Keap1-Nrf2 Signaling Pathway

Zijing Zhu et al.

Summary: The study demonstrates that MitoQ exerts a protective effect in Ang II-induced mitochondrial injury in podocytes by mitigating mitochondrial fission and ROS production via the Keap1-Nrf2 signaling pathway.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)

Article Cell Biology

Allopurinol reduces oxidative stress and activates Nrf2/p62 to attenuate diabetic cardiomyopathy in rats

Jierong Luo et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)

Review Cardiac & Cardiovascular Systems

Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence

Yi Tan et al.

NATURE REVIEWS CARDIOLOGY (2020)

Review Biochemistry & Molecular Biology

The Molecular Mechanisms Regulating the KEAP1-NRF2 Pathway

Liam Baird et al.

MOLECULAR AND CELLULAR BIOLOGY (2020)

Review Cell Biology

Reactive oxygen species (ROS) as pleiotropic physiological signalling agents

Helmut Sies et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)

Review Biochemistry & Molecular Biology

Molecular Mechanisms Responsible for Diastolic Dysfunction in Diabetes Mellitus Patients

Jovana Nikolajevic Starcevic et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Editorial Material Cardiac & Cardiovascular Systems

Diabetic Cardiomyopathy What Is It and Can It Be Fixed?

Wolfgang H. Dillmann

CIRCULATION RESEARCH (2019)

Review Biochemistry & Molecular Biology

Molecular Dysfunction and Phenotypic Derangement in Diabetic Cardiomyopathy

Isabella Evangelista et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Cardiac & Cardiovascular Systems

Diabetic Cardiomyopathy Definition, Diagnosis, and Therapeutic Implications

Stefania Paolillo et al.

HEART FAILURE CLINICS (2019)

Review Biochemistry & Molecular Biology

Nrf2-Keap1 signaling in oxidative and reductive stress

Ilaria Bellezza et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2018)

Review Cardiac & Cardiovascular Systems

Reactive Oxygen Species in Metabolic and Inflammatory Signaling

Steven J. Forrester et al.

CIRCULATION RESEARCH (2018)

Review Cardiac & Cardiovascular Systems

Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity

Guanghong Jia et al.

CIRCULATION RESEARCH (2018)

Review Biochemistry & Molecular Biology

Clinical Approach to Diabetic Cardiomyopathy: A Review of Human Studies

Roberto Tarquini et al.

CURRENT MEDICINAL CHEMISTRY (2018)

Review Cardiac & Cardiovascular Systems

Implications of Underlying Mechanisms for the Recognition and Management of Diabetic Cardiomyopathy

Thomas H. Marwick et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)

Review Medicine, General & Internal

Amyotrophic Lateral Sclerosis: An Update for 2018

Bjorn Oskarsson et al.

MAYO CLINIC PROCEEDINGS (2018)

Review Cell Biology

Nrf2 at the heart of oxidative stress and cardiac protection

Qin M. Chen et al.

PHYSIOLOGICAL GENOMICS (2018)

Article Instruments & Instrumentation

Curcumin-loaded self-nanomicellizing solid dispersion system: part I: development, optimization, characterization, and oral bioavailability

Ankit Parikh et al.

DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2018)

Article Neurosciences

Edaravone Reduces Iron-Mediated Hydrocephalus and Behavioral Disorder in Rat by Activating the Nrf2/HO-1 Pathway

Jianbo Zhang et al.

JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2018)

Article Cardiac & Cardiovascular Systems

Alogliptin prevents diastolic dysfunction and preserves left ventricular mitochondrial function in diabetic rabbits

Xiaowei Zhang et al.

CARDIOVASCULAR DIABETOLOGY (2018)

Review Endocrinology & Metabolism

Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease

Guanghong Jia et al.

DIABETOLOGIA (2018)

Article Pharmacology & Pharmacy

Effect of edaravone in diabetes mellitus-induced nephropathy in rats

Rajavel Varatharajan et al.

KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY (2016)

Article Multidisciplinary Sciences

Edaravone alleviates Alzheimer's disease-type pathologies and cognitive deficits

Shu-Sheng Jiao et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

Article Cardiac & Cardiovascular Systems

Structural changes in the myocardium during diabetes-induced cardiomyopathy

Ernest Adeghate et al.

HEART FAILURE REVIEWS (2014)

Review Pharmacology & Pharmacy

Diabetic cardiomyopathy: Mechanisms and new treatment strategies targeting antioxidant signaling pathways

Karina Huynh et al.

PHARMACOLOGY & THERAPEUTICS (2014)

Review Endocrinology & Metabolism

Modeling type 2 diabetes in rats using high fat diet and streptozotocin

Sos Skovso

JOURNAL OF DIABETES INVESTIGATION (2014)

Review Pharmacology & Pharmacy

Role of Nrf2 in Oxidative Stress and Toxicity

Qiang Ma

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 53, 2013 (2013)

Review Biochemistry & Molecular Biology

The Efficacy of Edaravone (Radicut), a Free Radical Scavenger, for Cardiovascular Disease

Kiyoshi Kikuchi et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)

Article Cardiac & Cardiovascular Systems

Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation

Yang Bai et al.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2013)

Article Cardiac & Cardiovascular Systems

Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment

Ines Falcao-Pires et al.

HEART FAILURE REVIEWS (2012)

Review Biochemistry & Molecular Biology

Oxidative stress in health and disease: The therapeutic potential of Nrf2 activation

Brooks M. Hybertson et al.

MOLECULAR ASPECTS OF MEDICINE (2011)

Article Pharmacology & Pharmacy

Edaravone, a Free Radical Scavenger, Protects against Retinal Damage in Vitro and in Vivo

Yuta Inokuchi et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)

Article Pharmacology & Pharmacy

Effects of edaravone on singlet oxygen released from activated human neutrophils

Piyanart Sommani et al.

JOURNAL OF PHARMACOLOGICAL SCIENCES (2007)